Atossa Therapeutics is a clinical-stage biopharmaceutical company focusing on breast cancer treatment and other breast conditions.
Employees: 11-50
Total raised: $6.6M
Founded date: 2009
Investors 1
| Date | Name | Website |
| - | Keiretsu F... | keiretsufo... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.06.2011 | - | $6.6M | - |
Mentions in press and media 5
| Date | Title | Description |
| 15.05.2013 | Angelina’s alternative: New test spots breast cancer risk at cellular level | A doctor collects fluid from each breast and sends the samples to Atossa’s CLIA-certified lab in Seattle, Washington. The National Reference Laboratory for Breast Health uses a proprietary analysis to study the fluid for precancerous cells.... |
| 01.02.2012 | Keiretsu NW Invested $24M in 2011, Highest Ever in Region | Share Share on Facebook Share on Twitter LinkedIn Email Reprints The Northwest chapter of angel investment group Keiretsu Forum says its members invested $24 million in 36 companies last year, the highest total since the regional group was ... |
| 27.06.2011 | Atossa raises $6.6M to roll out a ‘Pap test for breast cancer’ | Atossa Genetics, which is developing testing technologies to detect the presence of breast cancer, has raised $6.6 million in new financing in an oversubscribed round. The Seattle company plans to use the funds to bring its MACST System to ... |
| 27.06.2011 | Atossa Genetics Completes $6.6M Financing Round | Atossa Genetics, Inc., a Seattle, WA-based health care company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer, has completed a $6.6m financing round. Investors ... |
| - | Angelina’s alternative: New test spots breast cancer risk at cellular level | There is a new screening for breast cancer that could have allowed Angelina Jolie to choose watchful waiting instead of a double mastectomy. Earlier this year, Atossa Genetics launched the ForeCYTE Breast Health Test. The test uses a device... |